Cite
HARVARD Citation
Emery, P. et al. (2017). A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the rheumatic diseases. 76 (1), pp. 51-57. [Online].